REGULARLY MENSTRUATING premenopausal women
|
|
- Kevin Cooper
- 6 years ago
- Views:
Transcription
1 X/00/$03.00/0 Vol. 85, No. 12 The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright 2000 by The Endocrine Society Preserved Forearm Endothelial Responses with Acute Exposure to Progesterone: A Randomized Cross-Over Trial of 17- Estradiol, Progesterone, and 17- Estradiol with Progesterone in Healthy Menopausal Women* KIEREN J. MATHER, ERIC G. NORMAN, JERILYNN C. PRIOR, AND THOMAS G. ELLIOTT Division of Endocrinology (K.J.M.), Indiana University School of Medicine, Indianapolis, Indiana; and University of British Columbia and Vancouver Hospital and Health Sciences Centre (E.G.N., J.C.P., T.G.E.), Department of Medicine, Division of Endocrinology and Metabolism, Vancouver, British Columbia, Canada V5Z 1C6 ABSTRACT Regularly menstruating women are relatively protected from cardiovascular disease. Epidemiological and endothelial function studies attribute this protection to estradiol (E 2 ), but both progesterone (P) and E 2 are normally present. A range of vascular effects of added progestins have been described, from neutral to detrimental, but the effects of P per se on endothelial function in humans have not been reported. We therefore investigated the acute effects of E 2, P, and E 2 combined with P, on endothelium-dependent and -independent forearm blood flow responses. Using venous occlusion plethysmography, forearm blood flow (FBF) was measured during acute brachial artery infusions, achieving physiologic levels of 17- -E 2, P, and 17- -E 2 with P in healthy menopausal women with no cardiovascular disease risk factors. Vehicle or hormones were infused, in random order, on 4 days, 1 week REGULARLY MENSTRUATING premenopausal women are relatively protected against cardiovascular disease (1). This effect cannot simply be attributed to the younger age of premenopausal (compared with menopausal) women because young women, after ovariectomy or with premature gonadal failure, also experience higher rates of cardiovascular disease (1). Attempts to understand this vascular protection have recently turned to studies of endothelial function, with a particular focus on the endothelial effects of estrogens. In menopausal women, chronic estrogen therapy has been shown to improve endothelium-dependent control of blood flow in the coronary (2, 3) and brachial artery vascular beds (4 8). Interestingly, acute exposure to estrogen has also been found to improve endothelium-dependent responses in the coronary arteries of postmenopausal women with vascular disease (9 13) and in the brachial arteries of women with (14 17) and without (14 18) cardiovascular risk factors. Received June 27, Revision received August 11, Accepted August 18, Address all correspondence and requests for reprints to: T. G. Elliott, M.B.B.S., FRCPC, Suite 380, 575 West 8th Avenue, Vancouver, British Columbia, Canada V5Z 1C6. * Supported by the British Columbia Endocrine Research Foundation (Vancouver, British Columbia, Canada). A clinical research fellow with the Alberta Heritage Fund for Medical Research. apart. Flow responses were measured during coinfusions of hormone with the endothelium-dependent vasodilator acetylcholine and the endothelium-independent vasodilator sodium nitroprusside. Twenty-seven healthy menopausal women were studied, and all had normal baseline endothelial responses. Small ( 15%), statistically nonsignificant increases in endothelium-dependent flow responses were seen after all acute hormone treatments. No impairment in response was seen with P alone or in combination with 17- -E 2. In healthy menopausal women without cardiovascular disease risk factors and without baseline defects in endothelial function, acute exposure to physiologic levels of 17- -E 2, P, and 17- -E 2 with P produced equivalent endothelium-dependent responses. These data suggest that P does not have detrimental vascular effects in humans. (J Clin Endocrinol Metab 85: , 2000) Comparatively little is known of the effects of progestagens on the vasculature (19). Menopausal declines in progesterone (P) levels precede those of estradiol (E 2 ) (20) and could play an important role in the loss of vascular protection. Across the menstrual cycle, vasodilatory influences of sex steroids are seen in both the follicular (estrogen only) and luteal (estrogen plus P) phases (21). Unfortunately, during the menstrual cycle, any vascular effects of P alone cannot be separated from the effects of E 2. Dissociation of estrogen and P secretion is, however, seen during cycles with ovulation disturbances, wherein E 2 is commonly secreted in physiologic amounts but P production is significantly diminished. In nonhuman primates (22) and in women with the polycystic ovary syndrome (23), such ovulation disturbances are associated with increased atherosclerosis, perhaps suggesting a protective role attributable to P. These studies suggest that P and E 2 both have important physiologic vascular effects. However, adding synthetic progestins to estrogen has produced (at best) neutral and (in some cases) detrimental effects on vascular responses (24 26). Important questions therefore remain regarding the role of P, as distinct from estrogen, in modulating endothelial responses. Therefore, we set out to define the acute effects of physiologic levels of P alone, and in combination with phys- 4644
2 PROGESTERONE AND FOREARM BLOOD FLOW 4645 iologic levels of 17 -E 2, on forearm endothelial function in healthy menopausal women. Subjects Materials and Methods We recruited healthy menopausal women without cardiovascular risk factors and without recent exposure to exogenous sex steroids. Menopausal status was defined as the absence of menstrual flow for 12 months and/or FSH 35 IU/mL. Exclusion criteria included the use of menopausal ovarian hormone therapy within the previous 6 months, diabetes mellitus (American Diabetes Association criteria), hypertension [blood pressure (BP) 140/90], hypercholesterolemia (total cholesterol 6.2 mmol/l), current smoking, and known coronary artery disease or symptoms of cardiac ischemia or failure. Aspirin and any prescribed or over-the-counter nonsteroids antiinflammatory medications were stopped at least 10 days before the first plethysmography session and avoided throughout the 4-week study. The study was approved by the University of British Columbia and the Vancouver Hospital and Health Sciences Center research ethics review boards. All participants provided written informed consent. FBF measurements Studies were performed in a quiet clinical laboratory maintained at 21 to 23 C. Subjects were asked to refrain from drinking alcohol- or caffeine-containing beverages for at least 24 h before the study. All solutions were infused at 1.0 ml/min (Harvard Apparatus, South Natick, MA) into the brachial artery of the nondominant arm via an epidural catheter (Concord Portex, Keene, NH) sealed with dental wax to a 27-guage dental needle (Sherwood Medical, St. Louis, MO). FBF was measured simultaneously in the infused arm and in the noninfused arm using venous occlusion plethysmography as reported previously (27). Both arms were supported at heart level. Before each set of measurements, circulation to the hand was prevented by inflation of a wrist cuff to 160 mm Hg. For each measurement, a cuff placed on the upper arm was inflated to 40 mm Hg to occlude venous egress. This was achieved by rapidly inflating a cuff (Model E10; Hokanson, Inc.) for 10 sec of every 20 sec. Dose-response profiles to brachial arterial infusions of the endothelium-dependent vasodilator acetylcholine (ACh, Iolab, Claremont, CA), and the endothelium-independent vasodilator sodium nitroprusside (SNP, Roche, Basel, Switzerland), were measured. On each study day, the following infusion sequence was observed: saline for 9 min; vehicle [ hormone(s)] for 20 min; SNP at 1, 3, and 10 g/min for 6 min at each concentration; vehicle [ hormone(s)] for 9 15 min to allow flow to return to baseline; and ACh at 3, 10, and 30 g/min for 4 min at each concentration. Except for the initial saline-only period, vehicle [ hormone(s)] was infused continuously. FBF was recorded during the last 3 min of each infusion. The FBF value used for statistical analysis was the mean of the last five flow measurements at a given drug dose. Data were expressed as absolute flow rates and percent increase from the immediately preceding baseline in the infused arm, and as the percent increase in the ratio of blood flow rates observed in the infused and noninfused arms (28). Because serial measurements were taken, the average of all flows for each vasodilator infusion was used as a summary measure (29, 30), and statistical tests were applied to this summary measure. Protocol Each participant was tested on four separate occasions at weekly intervals. On each occasion, FBF was measured, as above, during the constant infusion of one of four separate treatments chosen in random order: 1) vehicle (0.79% ethanol in 0.9% sodium chloride) without hormone; 2) 17- -E 2, mol/l (Sel-Win Chemicals, Ltd., Vancouver BC, Canada) in vehicle; 3) P, mol/l (Sel-Win Chemicals, Ltd.) in vehicle; or 4) E 2 and P in the above concentrations in vehicle. Hormone infusions and measurements We performed a pilot study in nine women to ensure that the hormone levels achieved were within physiologic target ranges (E 2, pmol/l; P, nmol/l). Initial 17- -E 2 dose and vehicle concentrations were taken from the literature (15), and the P dose was estimated from these values, assuming equal volumes of distribution and solubility and using the normal ratio of the two hormones during the luteal phase as a guide. These results guided an adjustment of administered concentrations of both hormones to the values reported above. Hormone levels were measured in a venous sample drawn from a dorsal hand vein or the antecubital fossa of the infused arm, at the end of the min hormone infusions. Commercial RIA assays (Coat-a- Count, Diagnostics Products, Los Angeles, CA) were used for E 2 and P. Analyses were performed in the Vancouver Hospital and Health Sciences Center clinical chemistry laboratory. Statistical analysis In our laboratory, the plethysmography technique has good repeatability, with a measured coefficient of variation of 15% on an individual on a single day and approximately 21% on separate days. Clinically meaningful changes in flow responses require approximately a 30% change in response. Therefore, we calculated that 24 subjects would be required to demonstrate such a response between any 2 infusions (2- sided 0.05, 0.80). Participant characteristics and hormone levels are presented as mean sd with ranges. Flow and flow ratio data are expressed as mean sem. Error bars on the figures represent 1 sem. The blood flow data were reasonably normally distributed, allowing parametric testing with repeated-measures ANOVA. After significant differences were found by ANOVA, post hoc pairwise analysis was performed using the Bonferonni/Dunn adjustment for multiple comparisons. A two-tailed value of P 0.05 was considered statistically significant. Statistical analysis was performed using Statview 5.0 (SAS Institute, Inc., Carey, NC). Results We studied 27 healthy menopausal women, yr old (mean sd; range, 45 65). None of the subjects had taken any menopausal ovarian hormone therapy previously. The duration from menopause was yr (range, ). All participants were normotensive (systolic BP, 124 2; diastolic BP, 81 1 mm Hg), nondiabetic, had normal cholesterol levels (total cholesterol, mmol/l), and were nonsmokers. In 5 subjects, cuff artifact precluded analysis of data from 1 or 2 study days. The statistical comparisons therefore include 22 subjects for comparisons of all 4 treatments, and 23 subjects for pairwise comparisons between individual treatments. Controls and baseline Neither the vehicle used for administering the hormones nor the hormones themselves significantly altered FBF. As has been reported by other laboratories (15), the ethanol in normal saline vehicle produced a significant decrease in FBF, compared with the saline control (saline FBF, vs. EtOH FBF, ml/100 ml min; P ). No change in FBF was seen during infusion of vehicle plus 17- -E 2 (vehicle, vs. E 2, ; P 0.56), vehicle plus P (vehicle, vs. P, ; P 0.51), or vehicle plus both hormones (vehicle, vs. E 2 P, ; P 0.47). In the absence of hormone (control day), baseline vehicle flows were ml/100 ml min, and dose responses to ACh and SNP were similar; mean peak flows of 24.5 and 19.1 ml/100 ml min, respectively, were observed (Tables 1 and 2). These values and the 5-fold increases in FBF observed at
3 4646 MATHER ET AL. JCE&M 2000 Vol. 85 No. 12 peak vasodilator doses are comparable with values found in normal premenopausal female subjects (unpublished observations) and greater than those observed in healthy male volunteers (the reference population in Ref. 31) in our laboratory. This, together with the finding that the peak ACh flows were not markedly diminished (relative to SNP flows), suggests that there was no baseline defect in endothelial function. Vasodilator flow responses with acute sex steroid exposure Acute exposure to physiologic concentrations of 17- -E 2, P, and the combination (in a randomized cross-over schema) produced small ( 15%) statistically nonsignificant enhancements in endothelium-dependent vasodilation (EDV). Peak percent increase without hormone averaged %; E 2 produced peak increases of %, P gave % increases, and the combination produced % increases (Fig. 1). Endothelium-independent vasodilation (EIV) was increased by a similar degree ( 15%, P not significant) after E 2 treatment, but no such changes were apparent with the other two treatments (Fig. 2). Importantly, there was no apparent detrimental effect of P alone or in combination with E 2. This was the case when considering either the absolute flow responses (Tables 1 and 2) or the percent increase from baseline (Figs. 1 and 2) in the treated arm. Increases in EDV responses, expressed as percent change in the ratio of flows in the infused and noninfused arms (28), were significant (Fig. 1, P by repeatedmeasures ANOVA). Pairwise comparison for treatments vs. control achieved statistical significance only for P infusion (P ). No changes in EIV responses were apparent using this ratio (P 0.19 by repeated-measures ANOVA). Overall, we did not see statistically significant increases in EDV or EIV responses after acute exposure to any of the hormone treatments. Our data suggest, if anything, small enhancements to EDV responses with all treatments. Importantly, no detrimental effects of P on EDV or EIV were seen. Sex steroid concentrations Baseline serum 17- -E 2 levels averaged pmol/l (range, ), and P levels were nmol/l (range, ). In a random subset of 10 patients, the hormone infusions achieved 17- -E 2 levels of (range, ) pmol/l, and P levels of (range, 10 31) nmol/l. These means fall within the luteal phase range of values for premenopausal women. Discussion In healthy menopausal women without cardiovascular disease risk factors, we observed unimpaired baseline endothelial function and found that acute infusion of 17- -E 2, P, or the combination (achieving physiologic concentrations) did not produce significant enhancements in vasodilator responses. There were no direct effects of physiologic levels of 17- -E 2 or P on flow. Importantly, endothelium-dependent vasodilator responses were preserved with acute exposure to P. Further, the change in EDV responses observed with 17- -E 2 alone was not altered by coexposure with P, and all three treatments gave similar trends to improved EDV. Endothelium-independent flow responses were not significantly altered by the hormone coinfusions. To our knowledge, these are the first data detailing blood flow responses to acute infusions of physiological levels of P, alone and with E 2,in humans. The use of ratios of blood flow rates in treated and control arms is intended to increase the sensitivity of plethysmography by correcting for minor systemic hemodynamic changes (28). Taken in this light, the suggestion of a beneficial effect of P is interesting (Fig. 1). However, this apparent effect was related principally to systemic, rather than local, changes (Table 1) and is difficult to interpret, in view of the lack of significant changes in blood flow in the treated arm. This observation does, however, further support the lack of detrimental effects of P on endothelial function. Acute effects of sex steroid hormones on the vasculature Our observations of a lack of acute effects of E 2 infusion are contrary to a body of literature reporting significant improvements in endothelium-dependent blood flow responses after acute infusions in the coronary (9 13) and brachial (15 18) arteries. Of these, relatively few studies have examined the effects of physiologic levels of sex steroids (10, 14, 15), and the majority of the subjects studied had significant coronary artery disease risk. One report included a subset of healthy postmenopausal women apparently similar to our subjects (15). However, these women demonstrated considerably diminished ACh-stimulated flows before E 2 infusion (mean peak flows, 14.4 ml/100 ml min), compared with those described in the present study (24.5 ml/100 ml min). Although direct comparisons between studies are problematic, our subjects unimpaired flows at baseline could account for the lack of further improvement. The single study in the literature with comparable methodologies had led us to anticipate impaired baseline re- TABLE 1. Endothelium-dependent flows Acute infusion Infused arm Noninfused arm Flow ratio ACh 3 ACh 10 ACh 30 ACh 3 ACh 10 ACh 30 ACh 3 ACh 10 ACh 30 Control 11.8 (1.3) 16.6 (1.8) 24.5 (3.3) 3.1 (0.3) 3.1 (0.3) 3.2 (0.3) 4.1 (0.5) 6.0 (0.7) 9.3 (1.4) 17- E (1.3) 15.7 (1.7) 23.2 (2.2) 2.8 (0.2) 2.8 (0.2) 3.0 (0.3) 3.9 (0.6) 5.9 (0.8) 8.3 (0.9) P 11.9 (1.1) 17.9 (1.7) 25.1 (2.0) 2.8 (0.3) 2.7 (0.2) 2.6 (0.2) 4.7 (0.5) 7.3 (0.7) 10.7 (1.1) 17- E 2 & P 10.9 (1.1) 16.9 (2.1) 24.4 (2.6) 2.8 (0.3) 2.9 (0.3) 3.1 (0.3) 4.3 (0.5) 5.9 (0.5) 8.2 (0.7) Forearm blood flow (ml/100 ml min) in the infused and noninfused arms, and ratio of the infused divided by the noninfused forearm blood flow (unitless). Response to acetylcholine (doses in g/min) during acute infusions of vehicle (control), 17- -E 2 ( mol/min), P ( mol/min), and both 17- -E 2 and P at the same rates. Values are mean SEM.
4 PROGESTERONE AND FOREARM BLOOD FLOW 4647 TABLE 2. Endothelium-independent flows Acute infusion Infused arm Noninfused arm Flow ratio SNP 1 SNP 3 SNP 10 SNP 1 SNP 3 SNP 10 SNP 1 SNP 3 SNP 10 Control 8.5 (0.7) 13.8 (1.6) 19.1 (2.5) 2.6 (0.2) 2.8 (0.3) 2.5 (0.2) 3.5 (0.3) 5.3 (0.6) 7.9 (0.8) 17- E (0.8) 14.1 (1.5) 20.4 (1.7) 3.0 (0.2) 3.1 (0.3) 3.0 (0.3) 3.3 (0.2) 4.5 (0.3) 7.3 (0.5) P 10.4 (1.0) 15.1 (1.3) 21.4 (1.4) 2.9 (0.2) 2.8 (0.2) 2.8 (0.2) 3.6 (0.3) 5.6 (0.4) 8.2 (0.6) 17- E 2 & P 9.9 (0.8) 14.7 (1.3) 19.9 (1.2) 3.1 (0.2) 3.2 (0.3) 2.8 (0.2) 3.3 (0.2) 5.0 (0.3) 7.5 (0.5) Forearm blood flow (ml/100 ml min) in the infused and noninfused arms, and ratio of the infused divided by the noninfused forearm blood flow (unitless). Flow response to sodium nitroprusside (doses in g/min) during acute infusions of vehicle (control), 17- -E 2 ( mol/min), P( mol/min), and both E 2 and P at the same rates. Values are mean SEM. FIG. 1. Endothelium-dependent responses to ACh during hormone coinfusion. Top, Percent change in blood flow rates in the treated arm; bottom, percent changes in blood flow ratio (infused to noninfused arm). All data are mean SEM. *,P sponses to EDV (15), and our sample sizes were estimated with the assumption that such dysfunction would be evident. The number of subjects studied did provide sufficient power to demonstrate a relevant change of approximately 30% in flow responses. The observation of approximately 15% increases in EDV responses above the robust baseline response is of uncertain significance, but we were simply not powered for this difference to be statistically significant. Therefore, although our data do not document beneficial effects of E 2, P, or the combination on endothelial function, in the setting of normal baseline function we cannot firmly exclude Type 2 statistical errors (i.e. concluding that no effect exists when, in fact, such an effect does exist). We can be more definitive that no harmful effects on endothelial function were evident with any of the infusions. FIG. 2. Endothelium-independent responses to SNP during hormone coinfusion. Top, Percent change in blood flow rates in the treated arm; bottom, percent changes in blood flow ratio (infused to noninfused arm). All data are mean SEM. Another potentially important difference between these studies is the concentration of 17- -E 2 achieved in the forearm. After adjustments to the administered doses, we achieved mid-normal luteal phase E 2 concentrations in our subjects, whereas the study by Gilligan et al. reported highnormal values. Whether this difference has a bearing on vascular function is an open question. P and endothelial function We did not find a detrimental effect of acute exposure to P on vascular endothelial function. This is an important addition to the described effects of progestins on the vasculature. Data from animal models of atherosclerosis suggest that medroxyprogesterone acetate alone is not beneficial and, in combination therapy, mitigates the beneficial effects of es-
5 4648 MATHER ET AL. JCE&M 2000 Vol. 85 No. 12 trogen therapy (32 35). P, however, has been shown to have less detrimental, or even neutral, vascular effects (34, 36 39). Studies in humans fall into two categories: studies of vascular changes across the normal menstrual cycle; and studies of the effects of menopausal ovarian hormone therapy on vascular responses. The physiologic effects of the normal menstrual cycle on endothelial function have been examined in three recent studies of healthy young women (21, 40, 41). Hashimoto and co-workers (21) found that during menstruation (early in the follicular phase), when hormone levels were at their nadir, flow-mediated dilation (FMD) was similar to that seen in men. FMD during both the late follicular (estrogen-predominant) and luteal (combination estrogen and P) phases were comparable, and both were significantly elevated, relative to the menstrual phase (21). This group also found improved endothelium-independent flows during both the follicular and luteal phases. Conflicting results are reported by English and co-workers (40), who found diminished FMD in the luteal phase, compared with the follicular phase. Observational data in menopausal women taking hormone replacement therapy is available from two cohort studies (24, 42). In both studies, subjects receiving combined estrogen and progestin (including medroxyprogesterone acetate) showed improvement in FMD equivalent to that of those treated with estrogen alone. Three intervention studies have used combination hormone replacement therapy and assessed vascular responses. No detrimental effect of P was seen in mildly hypercholesterolemic women given transdermal E 2 with cyclical intravaginal micronized P (25). Norethisterone with E 2 improved FMD in gonadotropin-suppressed young women, compared with their hypogonadal counterparts (43). However, no longterm beneficial effect on FMD was apparent with combined E 2 and norethisterone (26); design issues (lack of baseline flow measures, and vascular studies not standardized to timing of the treatment cycle) limit the interpretation of these data, however. In all of these studies, no frank detrimental effect of short- or long-term treatment with progestagens was evident, and only the latter study suggests that beneficial vascular effects of estrogen might be mitigated by concurrent synthetic progestin exposure. Our finding of a lack of detrimental effects with acute exposure to P is concordant with these data. Of note, however, long-term exposures can engender broader responses, including receptor down-regulation and alterations in the transcriptional profile, which limit the comparison of acute and chronic responses. Conclusion In healthy menopausal women, we observed preserved endothelium-dependent responses with acute exposure to physiologic levels of P or the combination of 17- -E 2 and natural P, compared with 17- -E 2 alone. These findings support suggestions that P may not exert the detrimental effects on endothelial function seen with synthetic progestins. Acknowledgments We thank our study participants for their dedication and enthusiasm. References 1. Colditz GA, Willett WC, Stampfer MJ, Rosner B, Speizer FE, Hennekens CH Menopause and the risk of coronary heart disease in women. N Engl J Med. 316: Herrington DM, Braden GA, Williams JK, Morgan TM Endothelialdependent coronary vasomotor responsiveness in postmenopausal women with and without estrogen replacement therapy. Am J Cardiol. 73: Roque M, Heras M, Roig E, et al Short-term effects of transdermal estrogen replacement therapy on coronary vascular reactivity in postmenopausal women with angina pectoris and normal results on coronary angiograms. J Am Coll Cardiol. 31: Pinto S, Virdis A, Ghiadoni L, et al Endogenous estrogen and acetylcholine-induced vasodilation in normotensive women. Hypertension. 29: Lieberman EH, Gerhard MD, Uehata A, et al Estrogen improves endothelium-dependent, flow-mediated vasodilation in postmenopausal women. Ann Intern Med. 121: Sudhir K, Jennings GL, Funder JW, Komesaroff PA Estrogen enhances basal nitric oxide release in the forearm vasculature in perimenopausal women. Hypertension. 28: Perregaux D, Chaudhuri A, Mohanty P, et al Effect of gender differences and estrogen replacement therapy on vascular reactivity. Metabolism. 48: Kawano H, Motoyama T, Fugiyama K, et al Gender difference in improvement of endothelium-dependent vasodilation after estrogen supplementation. J Am Coll Cardiol. 30: Guetta V, Quyyumi AA, Prasad A, Panza JA, Waclawiw M, Cannon RO The role of nitric oxide in coronary vascular effects of estrogen in postmenopausal women. Circulation. 96: Gilligan DM, Quyyumi AA, Cannon RO Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women. Circulation. 89: Reis SE, Au GS, Blumenthal RS, Resar JR, Zacur HA, Gerstenblith G, Brinker JA Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women. Circulation. 89: Collins P, Rosano GMC, Sarrel PM, et al B-estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease. Circulation. 92: Anderson TJ Acute effect of estrogen on metabolic coronary vasodilator responses to atrial pacing in postmenopausal women. Am J Cardiol. 82: Gilligan DM, Badar DM, Panza JA, Quyyumi AA, Cannon RO Effects of estrogen replacement therapy on peripheral vasomotor function in postmenopausal women. Am J Cardiol. 75: Gilligan DM, Badar DM, Panza JA, Quyyumi AA, Cannon RO Acute vascular effects of estrogen in postmenopausal women. Circulation. 90: Tagawa H, Shimokawa H, Tagawa T, Kuroiwa-Matsumoto M, Hirooka Y, Takeshita A Short-term estrogen augments both nitric oxide-mediated and non-nitric oxide-mediated endothelium-dependent forearm vasodilation in postmenopausal women. J Cardiovasc Pharmacol. 30: Volteranni M, Rosano GM, Coats A, Beale C, Collins P Estrogen acutely increases peripheral blood flow in postmenopausal women. Am J Med. 99: Al-Khalili F, Eriksson M, Landgren BM, Schenck-Gustafsson K Effect of conjugated estrogen on peripheral flow-mediated vasodilation in postmenopausal women. Am J Cardiol. 82: Samaan SA, Au CM Estrogen and cardiovascular function after menopause. J Am Coll Cardiol. 26: Prior JC Perimenopause: the complex endocrinology of the menopausal transition. Endocr Rev. 19: Hashimoto M Modulation of endothelium-dependent flow-mediated dilatation of the brachial artery by sex and menstrual cycle. Circulation. 92: Kaplan JR, Adams MR, Clarkson TB, Koritnik DR Psychosocial influences on female protection among cynomolgus monkeys. Atherosclerosis. 53: Birdsall MA, Farquhar CM, White HD Association between polycystic ovaries and extent of coronary artery disease in women having cardiac catheterization. Ann Intern Med. 126: Bush DE, Jones CE, Bass KM, Walters GK, Bruza JM, Ouyang P Estrogen replacement reverses endothelial dysfunction in postmenopausal women. Am J Med. 104: Gerhard M, Walsh BW, Tawakol A, et al Estradiol therapy combined with progesterone and endothelium-dependent vasodilation in postmenopausal women. Circulation. 98: Sorenson KE, Celermeyer DS, Spieghalter DJ, et al Non-invasive measurement of human endothelium dependent arterial responses: accuracy and reproducibility. Br Heart J. 74: Elliott TG, Cockcroft JR, Groop PH, Viberti GC, Ritter JM Inhibition
6 PROGESTERONE AND FOREARM BLOOD FLOW 4649 of nitric oxide synthesis in forearm vasculature of insulin-dependent diabetics: blunted vasoconstriction in patients with microalbuminuria. Clin Sci. 85: Benjamin N, Calver A, Collier J, Robinson B, Vallance P, Webb D Measuring forearm blood flow and interpreting the responses to drugs and mediators. Hypertension. 25: Petrie JR, Ueda S, Webb DJ, Elliott HL, Connell JM Endothelial nitric oxide production and insulin sensitivity. A physiologic link with implications for pathogenesis of cardiovascular disease. Circulation. 93: Matthews JN, Altman DG, Cambpell MJ, Royston P Analysis of serial measurements in medical research. BMJ. 300: Elliott TG, Barth JD, Mancini GB Effects of vitamin E on endothelial function in men following myocardial infarction. Am J Cardiol. 76: Williams JK, Honore EK, Washburn SA, Clarkson TB Effects of hormone replacement therapy on reactivity of atherosclerotic coronary arteries in cynomolgus monkeys. J Am Coll Cardiol. 24: Levine RL, Chen SJ, Durand J, Chen YF, Oparil S Medroxyprogesterone attenuates estrogen-mediated inhibition of neointima formation after balloon injury of the rat carotid artery. Circulation. 94: Minshall RD, Stanczyk FZ, Miyagawa K, et al Ovarian steroid protection against coronary artery hyperreactivity in rhesus monkeys. J Clin Endocrinol Metab. 83: Register TC, Adams MR, Golden DL, Clarkson TB Conjugated equine estrogens alone, but not in combination with medroxyprogesterone acetate, inhibit aortic connective tissue remodeling after plasma lipid lowering in female monkeys. Arterioscler Thromb Vasc Biol. 18: Miller VM, Vanhoutte PM Progesterone and modulation of endothelium-dependent responses in canine coronary arteries. Am J Physiol. 261:R1022 R Vedernikov YP, Liao QP, Jain V, Saade GR, Chwalisz K, Garfield RE Effect of chronic treatment with 17beta-estradiol and progesterone on endothelium-dependent and endothelium-independent relaxation in isolated aortic rings from ovariectomized rats. Am J Obstet Gynecol. 176: Hanke H, Hanke S, Finking G, et al Different effects of estrogen and progesterone on experimental atherosclerosis in female versus male rabbits. Quantification of cellular proliferation by bromodeoxyuridine. Circulation. 94: Adams MR, Kaplan JR, Manuck SB, et al Inhibition of coronary artery atherosclerosis by 17-beta estradiol in ovariectomized monkeys. Lack of an effect of added progesterone. Arteriosclerosis. 10: English JL, Jacobs LO, Green G, Andrews TC Effect of the menstrual cycle on endothelium-dependent vasodilation of the brachial artery in normal young women. Am J Cardiol. 82: Kawano H, Motoyama T, Kugiyama K, et al Menstrual cyclic variation of endothelium-dependent vasodilation of the brachial artery: possible role of estrogen and nitric oxide. Proc Assoc Am Phys. 108: McCrohon J, Adams MR, McCredie RJ, et al Hormone replacement therapy is associated with improved arterial physiology in healthy postmenopausal women. Clin Endocrinol (Oxf). 45: Yim SF, Lau TK, Sahota DS, Chung TH, Chang AZ, Haines CJ Prospective randomized study of the effect of add-back hormone replacement on vascular function during treatment with gonadotropin-releasing hormone agonists. Circulation. 98:
Acute Vascular Effects of Estrogen
786 Acute Vascular Effects of Estrogen in Postmenopausal Women David M. Gilligan, MD; Diane M. Badar, RN; Julio A. Panza, MD; Arshed A. Quyyumi, MD; Richard. Cannon III, MD Downloaded from http://ahajournals.org
More informationOBJECTIVES BACKGROUND METHODS RESULTS CONCLUSIONS
Journal of the American College of Cardiology Vol. 36, No. 7, 2000 2000 by the American College of Cardiology ISSN 0735-1097/00/$20.00 Published by Elsevier Science Inc. PII S0735-1097(00)01007-X Natural
More informationJournal of the American College of Cardiology Vol. 37, No. 5, by the American College of Cardiology ISSN /01/$20.
Journal of the American College of Cardiology Vol. 37, No. 5, 2001 2001 by the American College of Cardiology ISSN 0735-1097/01/$20.00 Published by Elsevier Science Inc. PII S0735-1097(01)01168-8 Attenuation
More informationAging is a well-documented cardiovascular risk factor.
Physical Activity Prevents Age-Related Impairment in Nitric Oxide Availability in Elderly Athletes Stefano Taddei, MD; Fabio Galetta, MD; Agostino Virdis, MD; Lorenzo Ghiadoni, MD; Guido Salvetti, MD;
More informationEstrogens vs Testosterone for cardiovascular health and longevity
Estrogens vs Testosterone for cardiovascular health and longevity Panagiota Pietri, MD, PhD, FESC Director of Hypertension Unit Athens Medical Center Athens, Greece Women vs Men Is there a difference in
More informationConduit Artery Constriction Mediated by Low Flow
Journal of the American College of Cardiology Vol. 51, No. 20, 2008 2008 by the American College of Cardiology Foundation ISSN 0735-1097/08/$34.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2008.01.049
More information5. Summary of Data Reported and Evaluation
326 5. Summary of Data Reported and Evaluation 5.1 Exposure data Combined estrogen progestogen menopausal therapy involves the co-administration of an estrogen and a progestogen to peri- or postmenopausal
More informationPostmenopausal hormones and coronary artery disease: potential benefits and risks
CLIMACTERIC 2007;10(Suppl 2):21 26 Postmenopausal hormones and coronary artery disease: potential benefits and risks R. A. Department of Obstetrics and Gynecology, Columbia University, New York, New York,
More informationVascular Reactivity Is Impaired in Genetic Females Taking High-Dose Androgens
1331 VASCULAR REACTIVITY Vascular Reactivity Is Impaired in Genetic Females Taking High-Dose Androgens ROBYN J. MCCREDIE, BSC,* JANE A. MCCROHON, MB, BS, FRACP,* LEO TURNER, RN, KAYE A. GRIFFITHS, DMU,*
More informationObservational studies suggest that postmenopausal hormone
Differential Effects of Oral and Transdermal Estrogen Replacement Therapy on Endothelial Function in Postmenopausal Women Satu Vehkavaara, MD; Tiina Hakala-Ala-Pietilä, MD; Antti Virkamäki, MD; Robert
More informationThe 6 th Scientific Meeting of the Asia Pacific Menopause Federation
Predicting the menopause The menopause marks the end of ovarian follicular activity and is said to have occurred after 12 months amenorrhoea. The average age of the menopause is between 45 and 60 years
More informationMenopausal hormone therapy currently has no evidence-based role for
IN PERSPECTIVE HT and CVD Prevention: From Myth to Reality Nanette K. Wenger, M.D. What the studies show, in a nutshell The impact on coronary prevention Alternative solutions Professor of Medicine (Cardiology),
More informationRegular Aerobic Exercise Augments Endothelium- Dependent Vascular Relaxation in Normotensive As Well As Hypertensive Subjects
Regular Aerobic Exercise Augments Endothelium- Dependent Vascular Relaxation in Normotensive As Well As Hypertensive Subjects Role of Endothelium-Derived Nitric Oxide Yukihito Higashi, MD, PhD; Shota Sasaki,
More informationEffects of Statins on Endothelial Function in Patients with Coronary Artery Disease
Effects of Statins on Endothelial Function in Patients with Coronary Artery Disease Iana I. Simova, MD; Stefan V. Denchev, PhD; Simeon I. Dimitrov, PhD Clinic of Cardiology, University Hospital Alexandrovska,
More informationData Alert #2... Bi o l o g y Work i n g Gro u p. Subject: HOPE: New validation for the importance of tissue ACE inhibition
Vascular Bi o l o g y Work i n g Gro u p c/o Medical Education Consultants, In c. 25 Sy l van Road South, We s t p o rt, CT 06880 Chairman: Carl J. Pepine, MD Professor and Chief Division of Cardiovascular
More informationHow HRT Hurts the Heart
How HRT Hurts the Heart Coronary artery disease (CAD) is a killer and recent studies have come up with evidence that HRT might have a role in increasing CAD among women. Why? Zaheer Lakhani, MD, FRCP For
More informationA study of brachial artery flow mediated dilatation and carotid intima media thickness in subjects having risk factors for coronary artery disease
International Journal of Advances in Medicine http://www.ijmedicine.com pissn 2349-3925 eissn 2349-3933 Original Research Article DOI: http://dx.doi.org/10.18203/2349-3933.ijam20171037 A study of brachial
More informationProspective, randomized, controlled study of the effect of hormone replacement therapy on peripheral blood flow velocity in postmenopausal women
FERTILITY AND STERILITY VOL. 70, NO. 2, AUGUST 1998 Copyright 1998 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Prospective, randomized,
More informationTherapeutic Cohort Results
Patient: PAGE LOVE DOB: January 11, 1983 Sex: F MRN: 1232704193 Order Number: J9020008 Completed: July 08, 2016 Received: July 02, 2016 Collected: July 01, 2016 Aum Healing Center Sarika Arora MD 332 Newbury
More informationCho et al., 2009 Journal of Cardiology (2009), 54:
Endothelial Dysfunction, Increased Carotid Artery Intima-media Thickness and Pulse Wave Velocity, and Increased Level of Inflammatory Markers are Associated with Variant Angina Cho et al., 2009 Journal
More informationLow & Ultra Low Dose HRT The Cardiovascular Impact
Low & Ultra Low Dose HRT The Cardiovascular Impact Wyeth Symposium, Turin 29 th Sept 2007 Nick Panay Consultant Gynaecologist Queen Charlotte s & Chelsea and Chelsea & Westminster Hospitals Honorary Senior
More informationHow to detect early atherosclerosis ; focusing on techniques
How to detect early atherosclerosis ; focusing on techniques Jang-Ho Bae, MD., PhD. Heart Center Konyang University Hospital Daejeon city, S. Korea Surrogates for Atherosclerosis Measures of endothelial
More informationBIOAUTOMATION, 2009, 13 (4), 89-96
Preliminary Results оf Assessment of Systolic and Diastolic Function in Patients with Cardiac Syndrome X Using SPECT CT Tsonev Sv. 1, Donova T. 1, Garcheva M. 1, Matveev M. 2 1 Medical University Sofia
More informationPERIMENOPAUSE. Objectives. Disclosure. The Perimenopause Perimenopause Menopause. Definitions of Menopausal Transition: STRAW.
PERIMENOPAUSE Patricia J. Sulak, MD Founder, Living WELL Aware LLC Author, Should I Fire My Doctor? Author, Living WELL Aware: Eleven Essential Elements to Health and Happiness Endowed Professor Texas
More informationImpairment of the Nitric Oxide Mediated Vasodilator Response to Mental Stress in Hypertensive But Not in Hypercholesterolemic Patients
1207 Impairment of the Nitric Oxide Mediated Vasodilator Response to Mental Stress in But Not in CARMINE CARDILLO, MD, CRESCENCE M. KILCOYNE, RN, MS, RICHARD O. CANNON, III, MD, JULIO A. PANZA, MD Bethesda,
More informationTherapeutic Cohort Results
Patient: SAMPLE PATIENT DOB: Sex: MRN: Menopause Plus - Salivary Profile Therapeutic Cohort Results Hormone Average Result QUINTILE DISTRIBUTION 1st 2nd 3rd 4th 5th Therapeutic Range* Estradiol (E2) 8.7
More informationProgesterone Within Ovulatory Menstrual Cycles Needed for Cardiovascular Protection: An Evidence-Based Hypothesis
Progesterone Within Ovulatory Menstrual Cycles Needed for Cardiovascular Protection: An Evidence-Based Hypothesis Jerilynn C. Prior, BA, MD, FRCPC, ABIM, ABEM a 2014, Jerilynn C. Prior, BA Journal Compilation
More informationPost-menopausal hormone replacement therapy. Evan Klass, MD May 17, 2018
Post-menopausal hormone replacement therapy Evan Klass, MD May 17, 2018 Are we really still talking about this? Are we really still talking about this? 1960-1975- estrogen prescriptions doubled. Pharma
More informationJournal of the American College of Cardiology Vol. 38, No. 7, by the American College of Cardiology ISSN /01/$20.
Journal of the American College of Cardiology Vol. 38, No. 7, 2001 2001 by the American College of Cardiology ISSN 0735-1097/01/$20.00 Published by Elsevier Science Inc. PII S0735-1097(01)01658-8 Modulation
More informationEndocrinology of the Female Reproductive Axis
Endocrinology of the Female Reproductive Axis girlontheriver.com Geralyn Lambert-Messerlian, PhD, FACB Professor Women and Infants Hospital Alpert Medical School at Brown University Women & Infants BROWN
More informationLearning Objectives. Peri menopause. Menopause Overview. Recommendation grading categories
Learning Objectives Identify common symptoms of the menopause transition Understand the risks and benefits of hormone replacement therapy (HRT) Be able to choose an appropriate hormone replacement regimen
More informationMETABOLIC RISK MARKERS IN WOMEN WITH POLYCYSTIC OVARIAN MORPHOLOGY
Vuk Vrhovac University Clinic Dugi dol 4a, HR-10000 Zagreb, Croatia Original Research Article Received: February 18, 2010 Accepted: March 3, 2010 METABOLIC RISK MARKERS IN WOMEN WITH POLYCYSTIC OVARIAN
More informationEffect of Medroxyprogesterone Acetate on Endothelium-Dependent Vasodilation in Postmenopausal Women Receiving Estrogen
Effect of Medroxyprogesterone Acetate on Endothelium-Dependent Vasodilation in Postmenopausal Women Receiving Estrogen Akihiko Wakatsuki, MD; Yuji Okatani, MD; Nobuo Ikenoue, MD; Takao Fukaya, MD Background
More informationThe Study of Endothelial Function in CKD and ESRD
The Study of Endothelial Function in CKD and ESRD Endothelial Diversity in the Human Body Aird WC. Circ Res 2007 Endothelial Diversity in the Human Body The endothelium should be viewed for what it is:
More informationRelationship Between Endothelial Dysfunction and Nitric Oxide Production in Young Male Smokers
J Cardiol 2001 ; 38: 21 28 Relationship Between Endothelial Dysfunction and Nitric Oxide Production in Young Male Smokers Tomoyuki Taku Takaharu Kotaro Sachie Minoru Shunsuke Iwao Kazuyuki Katsuharu Tohru
More informationHT: Where do we stand after WHI?
HT: Where do we stand after WHI? Hormone therapy and cardiovascular disease risk Experimental and clinical evidence indicate that hormone therapy (HT) reduces the risk of cardiovascular disease (CVD) Women
More informationReproductive FSH. Analyte Information
Reproductive FSH Analyte Information 1 Follicle-stimulating hormone Introduction Follicle-stimulating hormone (FSH, also known as follitropin) is a glycoprotein hormone secreted by the anterior pituitary
More informationNatural Hormones Replacement An Evidence and Practice Based Approach
Natural Hormones Replacement An Evidence and Practice Based Approach Andres Ruiz, PharmD, MSc, FACA President/Partner Stonegate Pharmacy PRESENTED BY THE AMERICAN COLLEGE OF APOTHECARIES 2830 SUMMER OAKS
More informationThe incidence of coronary artery disease is lower in
Chronic 17 -Estradiol Replacement Increases Nitric Oxide Mediated Vasodilation of Guinea Pig Coronary Microcirculation Loren P. Thompson, PhD; Gerard Pinkas, BS; Carl P. Weiner, MD Background Estrogen
More informationThe Framingham Coronary Heart Disease Risk Score
Plasma Concentration of C-Reactive Protein and the Calculated Framingham Coronary Heart Disease Risk Score Michelle A. Albert, MD, MPH; Robert J. Glynn, PhD; Paul M Ridker, MD, MPH Background Although
More informationThe vascular endothelium plays an important role in the. Clinical Investigation and Reports
Clinical Investigation and Reports Regular Aerobic Exercise Prevents and Restores Age-Related Declines in Endothelium-Dependent Vasodilation in Healthy Men Christopher A. DeSouza, PhD; Linda F. Shapiro,
More informationCentre for Menstrual Cycle and Ovulation Research at Eight: 2010 CeMCOR Anniversary Celebration
June 30, 2010 Centre for Menstrual Cycle and Ovulation Research at Eight: 2010 CeMCOR Anniversary Celebration by Dr. Jerilynn C. Prior, Scientific Director, Centre for Menstrual Cycle and Ovulation Research
More informationCoronary Heart Disease in Women Go Red for Women
Coronary Heart Disease in Women Go Red for Women Dr Fiona Stewart Green Lane Cardiovascular Service and National Women s Health Auckland City Hospital Auckland Heart Group Women are Different from Men
More informationEndothelium-dependent vasodilatation in forearm is impaired in stroke patients
Journal of Internal Medicine 26; 259: 569 575 doi:1.1111/j.1365-2796.26.1635.x Endothelium-dependent vasodilatation in forearm is impaired in stroke patients A. STENBORG 1, A. TERENT 1 & L. LIND 1,2 From
More informationIn the name of GOD. Animal models of cardiovascular diseases: myocardial infarction & hypertension
In the name of GOD Animal models of cardiovascular diseases: myocardial infarction & hypertension 44 Presentation outline: Cardiovascular diseases Acute myocardial infarction Animal models for myocardial
More informationNANCY FUGATE WOODS a a University of Washington
This article was downloaded by: [ ] On: 30 June 2011, At: 09:44 Publisher: Routledge Informa Ltd Registered in England and Wales Registered Number: 1072954 Registered office: Mortimer House, 37-41 Mortimer
More informationDoes Acute Improvement of Endothelial Dysfunction in Coronary Artery Disease Improve Myocardial Ischemia?
904 JACC Vol. 32, No. 4 MYOCARDIAL ISCHEMIA Does Acute Improvement of Endothelial Dysfunction in Coronary Artery Disease Improve Myocardial Ischemia? A Double-Blind Comparison of Parenteral D- and L-Arginine
More informationMENOPAUSE. a Division of Cardiology, Department of Medicine, Cedars-Sinai Research Institute, Cedars-Sinai Medical Center, and
MENOPAUSE Past oral contraceptive use and angiographic coronary artery disease in postmenopausal women: data from the National Heart, Lung, and Blood Institute sponsored Women s Ischemia Syndrome Evaluation
More informationEstrogens and progestogens
Estrogens and progestogens Estradiol and Progesterone hormones produced by the gonads are necessary for: conception embryonic maturation development of primary and secondary sexual characteristics at puberty.
More informationPostmenopausal hormone therapy - cardiac disease risks and benefits
Postmenopausal hormone therapy - cardiac disease risks and benefits Tomi S. Mikkola, MD Helsinki University Central Hospital Department of Obstetrics and Gynecology Helsinki, Finland Disclosures Speaker/consulting
More informationOne Day Hormone Check
One Day Hormone Check DOB: Sex: F MRN: Order Number: Completed: Received: Collected: Salivary Hormone Results Estradiol pmol/l >3330.0 Testosterone pmol/l
More informationRole of Endothelial Nitric Oxide in Shear Stress Induced Vasodilation of Human Microvasculature
Role of Endothelial Nitric Oxide in Shear Stress Induced Vasodilation of Human Microvasculature Diminished Activity in Hypertensive and Hypercholesterolemic Patients Oscar A. Paniagua, MD; Melissa B. Bryant,
More informationAmbulatory Care Conference
Ambulatory Care Conference David Stultz, MD August 28, 2002 Case Presentation 50 year old white female presents to ED with substernal chest pain. Pain started while driving, is left substernal in location
More informationOutline. Estrogens and SERMS The forgotten few! How Does Estrogen Work in Bone? Its Complex!!! 6/14/2013
Outline Estrogens and SERMS The forgotten few! Clifford J Rosen MD rosenc@mmc.org Physiology of Estrogen and estrogen receptors Actions of estrogen on bone BMD, fracture, other off target effects Cohort
More informationPractical aspects of preventing and managing atherosclerotic disease in post-menopausal women
European Heart Journal (1996) 17 {Supplement D), 32-37 Practical aspects of preventing and managing atherosclerotic disease in post-menopausal women J. M. Sullivan University of Tennessee, Memphis, TN,
More informationKing s Research Portal
King s Research Portal DOI: 10.1016/j.jacc.2017.10.093 Document Version Early version, also known as pre-print Link to publication record in King's Research Portal Citation for published version (APA):
More informationReceived: March 2008; in final form May 2008.
RELATIONSHIP BETWEEN BRACHIAL ARTERY FLOW- MEDIATED DILATION AND CAROTID ARTERY INTIMA MEDIA THICKNESS IN THE MIDDLE-AGED SUBJECTS WITH LOW CARDIOVASCULAR RISK GERMAINE SĂVOIU*, LAVINIA NOVEANU**, O. FIRA-MLADINESCU*,
More informationHaemostasis, thrombosis risk and hormone replacement therapy
Haemostasis, thrombosis risk and hormone replacement therapy Serge Motte Brussels 13.05.17 - MY TALK TODAY The coagulation cascade and its regulation Effects of hormone replacement therapy on haemostasis
More informationHRT in Perimenopausal Women. Dr. Rubina Yasmin Asst. Prof. Medicine Dhaka Dental College
HRT in Perimenopausal Women Dr. Rubina Yasmin Asst. Prof. Medicine Dhaka Dental College 1 This is the Change But the CHANGE is not a disease 2 Introduction With a marked increase in longevity, women now
More informationMicro Medical Limited. PO Box 6, Rochester Kent ME1 2AZ England T +44 (0) F +44 (0)
Limited PO Box 6, Rochester Kent ME1 2AZ England T +44 (0) 1634 893500 F +44 (0) 1634 893600 Email micromedical@viasyshc.com http://www.micromedical.co.uk Contents What is PulseTrace?................................................
More informationOrals,Transdermals, and Other Estrogens in the Perimenopause
Orals,Transdermals, and Other Estrogens in the Perimenopause Cases Denise Black, MD, FRCSC Assistant Professor, Obstetrics, Gynecology and Reproductive Sciences University of Manitoba 6/4/18 197 Faculty/Presenter
More informationClassification of Endothelial Dysfunction. Stefano Taddei Department of Internal Medicine University of Pisa, Italy
Classification of Endothelial Dysfunction Stefano Taddei Department of Internal Medicine University of Pisa, Italy Pathogenesis of atherosclerosis from endothelial dysfunction to clinical disease endothelial
More informationThe Role of Massage in Blood Circulation, Pain Relief, and the Recovery Process: Implications of Existing Research
The Role of Massage in Blood Circulation, Pain Relief, and the Recovery Process: Implications of Existing Research I. Basic Physiology of Circulation A. The Vascular Endothelium The endothelium is a complex
More informationBUSINESS. Articles? Grades Midterm Review session
BUSINESS Articles? Grades Midterm Review session REVIEW Cardiac cells Myogenic cells Properties of contractile cells CONDUCTION SYSTEM OF THE HEART Conduction pathway SA node (pacemaker) atrial depolarization
More informationVariation in carotid-femoral pulse wave velocity, augmentation pressure and augmentation index during different phases of menstrual cycle
A n n M e d P h y s i o l. 2018 ; 2 (3 ):27-3 2 Q u e n c h A c a d e m y o f M e d i c a l E d u c a t i o n a n d R e s e a r ch A n n a l s o f M e d i c a l P h y s i o l o g y w w w. a m p h y s i
More informationStrong inwardly rectifying potassium channels (a family of
Barium Reduces Resting Blood Flow and Inhibits Potassium-Induced Vasodilation in the Human Forearm Matthew Dawes, PhD, MRCP; Christine Sieniawska, BSc, MPhil; Trevor Delves, PhD, CChem, EurClinChem, FRSC;
More informationBiologist s and Investigator Perspective. Has Sloppy Communication Slowed Progress??
Biologist s and Investigator Perspective Has Sloppy Communication Slowed Progress?? Thomas B. Clarkson, D.V.M. Comparative Medicine Clinical Research Center Wake Forest University School of Medicine Winston-Salem,
More informationKAJARIN Pure Reflections of Nature
KAJARIN Pure Reflections of Nature FAQS - General Guidelines What is the dosage of the active ingredients in Kajarin products? 4 Balance has approximately 28.9mg of Progesterone per pump 4 Balance Plus
More informationWomen and Heart Disease
Women and Heart Disease The Very Latest in Cardiovascular Medicine and Surgery Gretchen L. Wells, MD, PhD, FACC Thomas Whayne Endowed Professor in Women s Heart Health Gill Heart Institute University of
More informationRelationship between serum glutathione peroxidase-1activity with endothelial dysfunction level in patients with coronary artery diseases
Relationship between serum glutathione peroxidase-1activity with endothelial dysfunction level in patients with coronary artery diseases Introduction Reactive oxygen species (ROS),such as superoxide and
More informationCardiovascular Complications of Diabetes
VBWG Cardiovascular Complications of Diabetes Nicola Abate, M.D., F.N.L.A. Professor and Chief Division of Endocrinology and Metabolism The University of Texas Medical Branch Galveston, Texas Coronary
More informationEffect of L-Arginine on Human Coronary Endothelium-Dependent and Physiologic Vasodilation
1220 JACC Vol. 30, No. 5 Effect of L-Arginine on Human Coronary Endothelium-Dependent and Physiologic Vasodilation ARSHED A. QUYYUMI, MD, FACC, NADER DAKAK, MD, JEAN G. DIODATI, MD, FACC, DAVID M. GILLIGAN,
More informationPCTH 400. Endothelial dysfunction and cardiovascular diseases. Blood vessel LAST LECTURE. Endothelium. High blood pressure
PCTH 400 LAST LECTURE Endothelial dysfunction and cardiovascular diseases. Classic Vascular pharmacology -chronic -systemic Local Vascular pharmacology -acute -targeted High blood pressure Blood pressure
More informationIn type 1 diabetes, there is a 3-fold increase in coronary
Endothelium-Dependent and -Independent Vascular Dysfunction in Type 1 Diabetes Role of Conventional Risk Factors, Sex, and Glycemic Control Norman Nor Chan, Patrick Vallance, Helen Martina Colhoun Objective
More informationTherapeutic Cohort Results
Patient: JANE DOE DOB: December 31, 1968 Sex: F MRN: Order Number: Completed: February 26, 2016 Received: February 26, 2016 Collected: February 26, 2016 One Day Hormone Check - Salivary Profile Therapeutic
More informationOcclusion cuff position is an important determinant of the time course and magnitude of human brachial artery flow-mediated dilation
Clinical Science (2000) 99, 261 267 (Printed in Great Britain) 261 Occlusion cuff position is an important determinant of the time course and magnitude of human brachial artery flow-mediated dilation Karen
More informationMedroxyprogesterone increases basal temperature: a placebo-controlled crossover trial in postmenopausal women*
FERTILITY AND STERILITY Copyright 1995 American Society for Reproductive Medicine Printed on acid-free paper in U. S. A. Medroxyprogesterone increases basal temperature: a placebo-controlled crossover
More informationJournal of the American College of Cardiology Vol. 33, No. 7, by the American College of Cardiology ISSN /99/$20.
Journal of the American College of Cardiology Vol. 33, No. 7, 1999 1999 by the American College of Cardiology ISSN 0735-1097/99/$20.00 Published by Elsevier Science Inc. PII S0735-1097(99)00128-X Individual
More informationWEIGHT GAIN DURING MENOPAUSE EMERGING RESEARCH
MENOPAUSE WHEN DOES IT OCCUR? The cessation of the menstrual cycle for one year. WEIGHT GAIN DURING MENOPAUSE EMERGING RESEARCH Jan Schroeder, Ph.D. Chair of The Department of Kinesiology California State
More informationVascular Effects of Synthetic or Natural Progestagen Combined With Conjugated Equine Estrogen in Healthy Postmenopausal Women
Vascular Effects of Synthetic or Natural Progestagen Combined With Conjugated Equine Estrogen in Healthy Postmenopausal Women Kwang Kon Koh, MD, PhD; Dong Kyu Jin, MD; Seong Hee Yang, MD; Seon-Kyu Lee,
More informationDisclosures. Learning Objectives. Effects of Hormone Therapy on the Metabolic Syndrome and Cardiovascular Disease. None
Effects of Hormone Therapy on the Metabolic Syndrome and Cardiovascular Disease Micol S. Rothman, MD Associate Professor of Medicine Endocrinology, Diabetes and Metabolism Clinical Director Metabolic Bone
More informationMenopausal Management: What Has Changed?
Menopausal Management: What Has Changed? Julia V. Johnson, M.D. Professor and Chair, OB/GYN University of Massachusetts Medical School UMass Memorial Medical Center Conflicts of Interest None Learning
More informationThe inhibition of CETP: From simply raising HDL-c to promoting cholesterol efflux and lowering of atherogenic lipoproteins Prof Dr J Wouter Jukema
The inhibition of CETP: From simply raising HDL-c to promoting cholesterol efflux and lowering of atherogenic lipoproteins Prof Dr J Wouter Jukema Dept Cardiology, Leiden University Medical Center, Leiden,
More informationPotential dangers of hormone replacement therapy in women at high risk
ESC meeting, Stockholm, August 30, 16.30-18.00, 2010 Potential dangers of hormone replacement therapy in women at high risk Karin Schenck-Gustafsson MD, PhD, FESC Professor, Chief consultant Department
More informationROLE OF HORMONAL ASSAY IN DIAGNOSING PCOD DR GAANA SREENIVAS (JSS,MYSURU)
ROLE OF HORMONAL ASSAY IN DIAGNOSING PCOD DR GAANA SREENIVAS (JSS,MYSURU) In 1935, Stein and Leventhal described 7 women with bilateral enlarged PCO, amenorrhea or irregular menses, infertility and masculinizing
More informationDepot medroxyprogesterone acetate (DMPA) is a widely
Long-Term Use of Contraceptive Depot Medroxyprogesterone Acetate in Young Women Impairs Arterial Endothelial Function Assessed by Cardiovascular Magnetic Resonance Morten B. Sorensen, PhD; Peter Collins,
More informationWEIGHT CHANGE AND ANDROGEN LEVELS DURING CONTRACEPTIVE TREATMENT OF WOMEN AFFECTED BY POLYCYSTIC OVARY
ENDOCRINE REGULATIONS, VOL. 40, 119-123, 2006 119 WEIGHT CHANGE AND ANDROGEN LEVELS DURING CONTRACEPTIVE TREATMENT OF WOMEN AFFECTED BY POLYCYSTIC OVARY J. VRBIKOVA, K. DVORAKOVA, M. HILL, L. STARKA Institute
More informationBlood Pressure Control and Hormone Replacement Therapy in Postmenopausal Women at Risk for Coronary Heart Disease
Clemson University TigerPrints Publications Public Health Sciences 4-2002 Blood Pressure Control and Hormone Replacement Therapy in Postmenopausal Women at Risk for Coronary Heart Disease James A. McCubbin
More informationEndocrine Update Mary T. Korytkowski MD Division of Endocrinology University of Pittsburgh
Endocrine Update 2016 Mary T. Korytkowski MD Division of Endocrinology University of Pittsburgh Disclosure of Financial Relationships Mary Korytkowski MD Honoraria British Medical Journal Diabetes Research
More informationFrequency of menses. Duration of menses 3 days to 7 days. Flow/amount of menses Average blood loss with menstruation is 60-80cc.
Frequency of menses 24 days (0.5%) to 35 days (0.9%) Age 25, 40% are between 25 and 28 days Age 25-35, 60% are between 25 and 28 days Teens and women over 40 s cycles may be longer apart Duration of menses
More informationAndrew Cohen, MD and Neil S. Skolnik, MD INTRODUCTION
2 Hyperlipidemia Andrew Cohen, MD and Neil S. Skolnik, MD CONTENTS INTRODUCTION RISK CATEGORIES AND TARGET LDL-CHOLESTEROL TREATMENT OF LDL-CHOLESTEROL SPECIAL CONSIDERATIONS OLDER AND YOUNGER ADULTS ADDITIONAL
More informationChapter-V. Summary, Conclusions and Recommendations
Summary, Conclusions and Recommendations INTRODUCTION The work included in this thesis entitled, Circadian heart rate and blood pressure variability in apparently healthy subjects using ABPM has been divided
More informationHeart Online First, published on March 29, 2005 as /hrt SCIENTIFIC LETTER
Heart Online First, published on March 29, 2005 as 10.1136/hrt.2004.056523 Manuscript ID: HEARTJNL/2004/056523 March 18, 2005 SCIENTIFIC LETTER Effects of HMG-CoA Reductase Inhibition on Endothelial Function
More informationOB/GYN Update: Menopausal Management What Does The Evidence Show? Rebecca Levy-Gantt D.O. PremierObGyn Napa Inc.
OB/GYN Update: Menopausal Management What Does The Evidence Show? Rebecca Levy-Gantt D.O. PremierObGyn Napa Inc. Napa, California IMPORTANT SAFETY INFORMATION ABOUT EVAMIST: WARNING: ENDOMETRIAL CANCER,
More informationPotential Applications:
How To Vascular Function in Animal and Clinical Study Yeungnam Univ. Hospital Jong-Seon Park, MD, PhD Vascular Function Test, When? Potential Applications: Identification of cardiovascular risk (e.g. patient
More informationMedroxyprogesterone acetate does not antagonize estrogen-induced increases in endothelium-dependent vasodilation: potential clinical implications
FERTILITY AND STERILITY VOL. 78, NO. 1, JULY 2002 Copyright 2002 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Medroxyprogesterone acetate
More informationThe widespread use of estrogen supplementation by hormone
Age Moderates the Short-Term Effects of Transdermal 17 -Estradiol on Endothelium-Dependent Vascular Function in Postmenopausal Women Andrew Sherwood, Julie K. Bower, Judith McFetridge-Durdle, James A.
More informationNitroglycerin (GTN) has been used for more than a
Folic Acid Prevents Nitroglycerin-Induced Nitric Oxide Synthase Dysfunction and Nitrate Tolerance A Human In Vivo Study Tommaso Gori, MD; Jason M. Burstein, MD; Sofia Ahmed, MD; Steve E.S. Miner, MD; Abdul
More informationSummary. Introduction
Clin Physiol Funct Imaging (2008) doi: 10.1111/j.1475-097X.2008.00816.x 1 Arterial compliance and endothelium-dependent vasodilation are independently related to coronary risk in the elderly: the Prospective
More informationConflict of Interest Slide
Comparison of six- month clinical outcomes, event free survival rates of patients undergoing enhanced external counterpulsation (EECP) for coronary artery disease in the United States and Europe Ozlem
More information